The modulation of class I and class II MHC molecules on intestinal epithelial cells at different stages of differentiation.
Nestlé Research Centre, Vers-chez-les-Blanc, Lausanne, Switzerland.
A
A
Donnet-Hughes
Y
Y
Borel
E J
EJ
Schiffrin
D000230:Adenocarcinoma / Q000276:immunology / Q000473:pathology; D000951:Antigens, Neoplasm / Q000096:biosynthesis / Q000235:genetics; D002454:Cell Differentiation / Q000187:drug effects; D003110:Colonic Neoplasms / Q000276:immunology / Q000473:pathology; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006680:HLA Antigens / Q000096:biosynthesis* / Q000235:genetics; D006684:HLA-DR Antigens / Q000096:biosynthesis* / Q000235:genetics; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology; D015847:Interleukin-4 / Q000494:pharmacology; D007413:Intestinal Mucosa / Q000166:cytology / Q000276:immunology*; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000276:immunology
D000951:Antigens, Neoplasm; D006680:HLA Antigens; D006684:HLA-DR Antigens; D015847:Interleukin-4; D007371:Interferon-gamma